| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.70▲ | 3.67▲ | 3.67▲ | 3.93▼ | 4.05▼ |
| MA10 | 3.68▲ | 3.68▲ | 3.72▲ | 3.95▼ | 4.46▼ |
| MA20 | 3.66▲ | 3.74▼ | 3.89▼ | 4.05▼ | 4.51▼ |
| MA50 | 3.67▲ | 3.95▼ | 3.97▼ | 4.62▼ | 2.90▲ |
| MA100 | 3.73▼ | 3.98▼ | 4.00▼ | 4.42▼ | N/A |
| MA200 | 3.90▼ | 4.03▼ | 4.16▼ | 3.21▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.007▲ | -0.022▼ | 0.004▲ | -0.226▼ |
| RSI | 66.823▲ | 40.434▼ | 36.621▼ | 37.081▼ | 47.631▼ |
| STOCH | 93.801▲ | 27.737 | 13.163▼ | 37.696 | 11.120▼ |
| WILL %R | 0.000▲ | -44.737 | -75.000▼ | -89.394▼ | -95.205▼ |
| CCI | 126.915▲ | 28.704 | -52.720 | -183.578▼ | -110.362▼ |
|
Tuesday, June 16, 2026 01:24 PM
Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
|
|
Monday, June 01, 2026 11:59 PM
RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...
|
|
Thursday, May 28, 2026 09:01 AM
RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/06/26 | 3.805 | 3.805 | 3.62 | 3.725 | 939,350 |
| 24/06/26 | 4.07 | 4.07 | 3.70 | 3.71 | 948,798 |
| 23/06/26 | 4.03 | 4.29 | 4.03 | 4.08 | 725,045 |
| 22/06/26 | 4.07 | 4.15 | 3.99 | 4.08 | 849,396 |
| 18/06/26 | 4.17 | 4.26 | 4.035 | 4.07 | 1,056,307 |
| 17/06/26 | 3.88 | 4.25 | 3.8704 | 4.06 | 1,065,157 |
| 16/06/26 | 3.91 | 3.975 | 3.80 | 3.90 | 755,093 |
| 15/06/26 | 4.12 | 4.14 | 3.8921 | 3.915 | 641,401 |
| 12/06/26 | 3.94 | 4.17 | 3.92 | 4.04 | 688,840 |
| 11/06/26 | 3.90 | 3.975 | 3.84 | 3.91 | 525,715 |
|
|
||||
|
|
||||
|
|